FINAL AWARD

Mar 16, 2017 - Respondent. Case No. UNCT/14/2 ... Mark A. Luz. Adrian Johnston ...... Canadian Federal Court decision dated 14 September 2010, finding the ...
1MB Sizes 3 Downloads 176 Views
INTERNATIONAL CENTRE FOR SETTLEMENT OF INVESTMENT DISPUTES IN AN ARBITRATION UNDER CHAPTER ELEVEN OF THE NAFTA AND THE UNCITRAL ARBITRATION RULES, 1976

between

ELI LILLY AND COMPANY Claimant

and

GOVERNMENT OF CANADA Respondent

Case No. UNCT/14/2

FINAL AWARD

Members of the Tribunal Professor Albert Jan VAN DEN BERG (President) Sir Daniel BETHLEHEM QC Mr. Gary BORN Secretary of the Tribunal Ms. Lindsay GASTRELL

Date of dispatch to the Parties: 16 March 2017

REPRESENTATION OF THE PARTIES Representing Eli Lilly and Company:

Representing the Government of Canada:

Richard G. Dearden Wendy J. Wagner Anca M. Sattler GOWLING LAFLEUR HENDERSON LLP 160 Elgin Street, Suite 2600 Ottawa, Ontario, K1P 1C3 Canada

Sylvie Tabet Shane Spelliscy Mark A. Luz Adrian Johnston Mariella Montplaisir Michelle Hoffmann Krista Zeman TRADE LAW BUREAU Departments of Justice and of Foreign Affairs, Trade and Development 125 Sussex Drive Ottawa, Ontario, K1A OG2 Canada

and Marney L. Cheek John K. Veroneau Alexander A. Berengaut James M. Smith Nikhil V. Gore Lauren S. Willard COVINGTON & BURLING LLP One City Center, 850 Tenth St., NW Washington, DC 20001 United States of America

i

TABLE OF CONTENTS LIST OF DEFINED TERMS......................................................................................................... vi INTRODUCTION ................................................................................................................. 1 Parties ........................................................................................................................... 1 Overview ........................................................................................................................ 1 PROCEDURE ........................................................................................................................ 3 BACKGROUND TO THE DISPUTE ................................................................................. 18 Canadian Patent Law .................................................................................................... 18 Zyprexa Patent (Olanzapine) ........................................................................................ 20 Strattera Patent (Atomoxetine) ..................................................................................... 23 REQUESTS FOR RELIEF .................................................................................................. 25 Relief Sought by Claimant ........................................................................................... 25 Relief Sought by Respondent ....................................................................................... 26 INTRODUCTION TO THE TRIBUNAL’S ANALYSIS ................................................... 26 The Jurisdiction of the Tribunal and Questions of Applicable Law ............................ 26 Burden of Proof ............................................................................................................ 29 Roadmap to the Tribunal’s Analysis ............................................................................ 29 JURISDICTION .................................................................................................................. 30 Applicable Law ............................................................................................................ 30 The Parties’ Positions ................................................................................................... 30 Respondent’s Position........................................................................................... 31 a. Timeliness of Respondent’s Jurisdictional Objection ................................... 31 b. Claimant’s Compliance with NAFTA Articles 1116(2) and 1117(2) ........... 33 Claimant’s Position .............................................................................................